Study evaluates cost-effectiveness of olaparib for metastatic pancreatic cancer
Studies have shown that utilising a PARP inhibitor in the management of patients with metastatic…
Browsing: metastatic pancreatic cancer
Preventing pancreatic cancer metastasis by keeping cells ‘sheltered in place’
Scientists at Sanford Burnham Prebys Medical Discovery Institute, USA, have shown that pancreatic cancer metastasis…
Platinum-based chemo may improve survival for some metastatic pancreatic cancer patients
Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes…
ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer
The randomised, phase III POLO trial found that maintenance therapy with the PARP inhibitor olaparib…